Osteoarthritis: Understanding the pathophysiology, genetics, and treatments

Journal of the National Medical Association

Volumn 95, Issue 6, 2003, Pages 475-482

  Sinkov, Vladamir ^a   Cymet, Tyler ^a  

^a NONE

Author keywords

Chondrocytes; Degenerative joint disease; Joint pain; NSAIDS; Osteoarthritis; Osteophyte; Osteotomy; Subluxation; Symptomatic slow acting drugs for osteoarthritis (SYSADOA)

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DIACETYLRHEIN; GLUCOSAMINE SULFATE; HYALURONIC ACID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; STEROID; TRAMADOL;

AGE; ARTHRALGIA; ARTHROPATHY; BIOCHEMICAL COMPOSITION; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; GENETICS; HUMAN; JOINT FUNCTION; JOINT INJURY; LABORATORY TEST; LIVER TOXICITY; MANIPULATIVE MEDICINE; NEPHROTOXICITY; OSTEOARTHRITIS; OSTEOTOMY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TENDON RUPTURE;

HUMANS; OSTEOARTHRITIS; RISK FACTORS;

EID: 0041735145     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. NIH. Dept of Health and Human services. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Handouts on Health: Osteoarthritis. On the Web at www.niams.nih.gov/hi/topics/arthritis/oahandout.htm. Feburary 2000.
2. Demissie S, Cupples LA, Myers R, et al. Genome scan for quantity of hand osteoarthritis: the Framingham Study. Arthritis Rheum. 2002;46:946-952.
3. Mnakin HI, Brandt KD: Pathophysiology of Osteoarthritis. In Ruddy: Kelley's Textbook of Rheumatology, 6th ed., Philadelphia, W.B. Saunders, 2001, p. 1391.
4. Mankin HJ, Brandt KD: Biochemistry and metabolism of cartilage in osteoarthritis. In Moskowitz RW, Howell DS, Goldberg VM, et al (eds): Osteoarthritis: Diagnosis and Management, 2nd ed. Philadelphia, WB Saunders, 1992, p 109.
5. Stewart A, Black A, Robins SP, Reid DM. Bone density and bone turnover in patients with OA and osteoporosis. J Rheumatol 1999;26:622-626.
6. Burger H, van Daele PL, Odding E, et al. Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age: The Rotterdam Study. Arthritis Rheum. 1996;39:81-86.
7. Brandt KD: Osteoarthritis. In Braunwald E, Fauci AS, Kasper DL, et al (eds): Harrissons's Principles of Internal Medicine, 15th ed. Philadelphia, McGraw-Hill Companies, 2001.
8. Bradley JD, Brandt KD, Katz BP, et al. Treatment of knee osteoarthritis: Relationship of clinical features of joint inflammation to the response to a nonsteroidal anti-inflammatory drug or pure analgesic. J Rheumatol. 1992;19:1950.
9. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635-646.
10. Lapvetelainen T, Hyttinen M, Lindblom J, et al. More knee joint osteoarthritis (OA) in mice after inactivation of one allele of type II procollagen gene but less OA after lifelong voluntary wheel running exercise. Osteoarthritis Cartillage. 2001;9:152-160.
11. Ettinger WH Jr, Bums R, Messier SP, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee oteoarthritis: the Fitness Arthitis and Seniors Trial (FAST). JAMA. 1997;277:25-31.
12. Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997;127:97-104.
13. Spector TD, Cicuttini F, Baker J, et al. Genetic influences on osteoarthritis in women: a twin study. BMJ. 1996;312:940-943.
14. Wright GD, Hughes AE, Regan M, et al. Association of two loci on chromosome 2q with nodal osteoarthritis. Ann Rheum Dis. 1996;55:317-319.
15. Chapman K, Mustafa Z, Irven C, et al. Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet. 1999;65:167-174.
16. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the Medical Management of Osteoarthrits of the Hip and Knee. Arthritis Rheum. 2000;43:1905-1915.
17. Moore RA, Carroll D, Wiffen PJ, et al. A systematic review of topically-applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316:333-338.
18. A Pendleton, N Arden, M Dougados, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000;59:936-944.
19. Listrat V, Ayral X, Patarnello F, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997;5:153-160.
20. Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chrondroitin sulphate 1200 mg/day vs chondroitin sulphate 3 × 400 mg/day vs placebo. Osteoarthritis Cartilage. 1998;6(supp):25-30.
21. Muller-Fassbender H, Bach GL, Haase W, et al. Glucosamine sulphate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994;2:61-69.
22. Ramsey SD, Spencer AC, Topolski TD, et al. Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum. 2001 Jun;45:222-227.
23. Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;CD002947.
24. Choi JH, Choi JH, Kim DY, et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage. 2002;10:471-478.
25. Berman BM. The evidence for acupuncture as a treatment for rheumatologic conditions. Rheum Dis Clin North Am. 2000;26:103-115.
26. Hartman CA. Effects of T'ai Chi training on function and quality of life indicators in older adults with osteoarthritis. J Am Geriatr Soc. 2000;48:1553-1559.
27. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39:237-246.
28. CDC. Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR. 2001;50:120-125.
29. Angst F, Aeschlimann A, Steiner W, et al. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis. 2001;60:834-840.
30. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis: Classification of osteoarthritis of the knee. Annals of Internal Medicine. 1992;116:535-539.
31. Rejeski WJ, Focht BC, Messier SP, et al. Obese, older adults with knee osteoarthritis: weight loss, exercise, and quality of life. Health Psychol. 2002;21:419-426.
32. Wilson MG, May DS, Kelly JJ. Racial differences in the use of total knee arthroplasty for osteoarthritis among older Americans. Ethn Dis. 1994;4:57-67.
33. Hoagland FT, Oishi CS, Gialamas GG. Extreme variations in racial rates of total hip arthroplasty for primary coxarthrosis: a population-based study in San Francisco. Ann Rheum Dis. 1995;54:107-10.
34. Ibrahim SA, Siminoff LA, Burant CJ, et al. Differences in Expectations of Outcome Mediate African American/White Patient Differences in "Willingness" to Consider Joint Replacement. Arthritis Rheum. 2002;46:2429-2435.
35. Katz JN. Preferences, quality, and the (under) utilization of total joint replacement. Med Care. 2001;39:203-205.
36. Michalsen A, Moebus S, Spahn G, et al. Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study. Altern Ther Health Med. 2002;8:84-88.
37. CDC. Prevalence and Impact of Arthritis by Race and Ethnicity-United States, 1989-1991. MMWR. 1996;45:373-378.